semaglutide + methylcobalamin FDA alerts health care providers,
Description
Tolerability Pramlintide treatment has been generally well tolerated in patients with diabetes
More clinical trials are needed in the future to verify the causal relationships
Personalized GLP-1 may also be a more cost-effective option for some patients
Regular check-ins ensure safety, progress tracking, and adjustments as needed
[1] Diarrhoea specifically was among the most frequently cited individual symptoms, though the majority of episodes were described as mild to moderate in severity
